Measles Cases Rising in England: 2026 Data & London Outbreak

The rise in measles cases across England, particularly concentrated in London, is prompting renewed attention to vaccination rates and potential public health impacts. Figures regularly published by the UK Health Security Agency (UKHSA) show that cases of measles have been increasing since the start of 2026. As of January 1, 2026, a total of 158 laboratory-confirmed cases have been reported in England, with a significant majority – 66% (104 cases) – occurring in London. The West Midlands accounts for another 21% (33 cases).

Understanding the Current Situation

Measles is a highly contagious viral infection that can cause serious complications, especially in young children and individuals with weakened immune systems. It’s characterized by a fever, cough, runny nose, and a distinctive rash. While generally preventable through vaccination, the recent increase in cases signals a potential decline in population immunity. The UKHSA is actively monitoring the situation and working to understand the factors contributing to this resurgence.

The current outbreak isn’t happening in a vacuum. Globally, the World Health Organization (WHO) has reported a surge in measles cases in many regions, reversing decades of progress towards elimination. This global trend underscores the importance of maintaining high vaccination coverage to protect communities.

Who is Most Vulnerable?

The primary risk is to individuals who have not been fully vaccinated against measles. This includes young children who are too young to receive the MMR (measles, mumps, and rubella) vaccine, as well as individuals who have chosen not to be vaccinated or who have missed doses. Lower vaccination rates in specific communities create pockets of susceptibility, increasing the risk of outbreaks. The UKHSA data highlights London as a particular area of concern, suggesting that vaccination coverage may be lower in certain parts of the city.

It’s important to note that even those who have been vaccinated can, in rare cases, contract measles, though the illness is typically milder. However, vaccination significantly reduces the risk of severe complications, such as pneumonia, encephalitis (inflammation of the brain), and even death.

What Does the Data Notify Us?

The 158 confirmed cases represent a notable increase compared to previous years, although it’s crucial to contextualize this figure. While concerning, it’s still relatively low compared to pre-vaccination levels. The UKHSA’s ongoing surveillance is vital for tracking the spread of the virus and identifying areas where targeted interventions are needed. The agency’s weekly reports, monitoring respiratory viruses, provide a continuous stream of data for public health officials.

The concentration of cases in London and the West Midlands suggests localized outbreaks, potentially linked to specific communities or events. Further investigation is needed to determine the source of these outbreaks and to implement effective control measures. The UKHSA is likely analyzing epidemiological data to identify common links between cases, such as travel history or social networks.

Measles and Immunity: A Closer Look

Measles is one of the most contagious viruses known. It spreads through the air when an infected person coughs or sneezes. The virus can remain infectious in the air for up to two hours and on surfaces for up to 24 hours. This high transmissibility means that even brief exposure can lead to infection in unvaccinated individuals.

The MMR vaccine provides excellent protection against measles, but it requires two doses for full immunity. The first dose is typically given to infants around 12-15 months of age, and the second dose is given between 3 and 5 years old. Maintaining high vaccination coverage – ideally above 95% – is essential for achieving herd immunity, which protects those who cannot be vaccinated.

Public Health Response and What Comes Next

The UKHSA is taking several steps to address the rising measles cases. These include enhanced surveillance, targeted vaccination campaigns, and public awareness initiatives. The agency is as well working with healthcare professionals to ensure that they are aware of the current situation and are prepared to diagnose and manage cases effectively. Recent UKHSA advisories, such as the one urging eligible individuals to receive the free shingles vaccine, demonstrate a proactive approach to preventative healthcare.

The agency recently published its first Cold Mortality Report, highlighting the impact of cold weather on health, demonstrating a broad scope of public health monitoring. This illustrates the UKHSA’s commitment to understanding and mitigating a range of health risks.

Looking ahead, the UKHSA will continue to monitor the situation closely and to adapt its response as needed. This may involve further vaccination campaigns, particularly in areas with low coverage, and the implementation of additional control measures, such as contact tracing. The agency will also be reviewing its vaccination strategies to ensure that they are effective in protecting the population. The UKHSA can be contacted for research enquiries at [email protected].

For the most up-to-date information and guidance on measles, it is recommended to check the official UKHSA website and consult with a qualified healthcare professional. The NHS website also provides comprehensive information on the MMR vaccine and measles prevention: https://www.nhs.uk/conditions/measles/.